Navigation Links
DURECT Signs Long Term Excipient Supply Agreement With King Pharmaceuticals for REMOXY(R)
Date:8/27/2009

safety for small molecule and biologic drugs. For more information, please visit www.durect.com.

NOTE: POSIDUR(TM), SABER(TM), ORADUR(TM), TRANSDUR(TM), and ELADUR(TM) are trademarks of DURECT Corporation. Other referenced trademarks belong to their respective owners. REMOXY, POSIDUR, ELADUR and TRANSDUR-Sufentanil are drug candidates under development and have not been approved for commercialization by the US Food and Drug Administration or other health authorities.

DURECT Forward-Looking Statement

The statements in this press release regarding REMOXY, its potential attributes and statements related to plans by King Pharmaceuticals for resubmission of the REMOXY NDA, including the timing of such resubmission, the potential of FDA approving the REMOXY NDA, as well as the potential royalty and other payments that may be received by DURECT from REMOXY and other described products are forward-looking statements involving risks and uncertainties that can cause actual results to differ materially from those in such forward-looking statements. Potential risks and uncertainties include, but are not limited to, the potential that the REMOXY NDA resubmission may not adequately address all of FDA's concerns, the potential that FDA may not grant regulatory approval of REMOXY, difficulties or delays in the development, testing, regulatory approval, production and commercialization of REMOXY, and unexpected adverse side-effects or inadequate therapeutic efficacy of REMOXY that could slow or prevent product approval or market acceptance (including the risk that current and past results of clinical trials and tests are not necessarily indicative of future results of clinical trials and tests). Further information regarding these and other risks is included in DURECT's Form 10-Q dated August 4, 2009 under the heading "Risk Factors.
'/>"/>

SOURCE DURECT Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. DURECT Announces License of ADHD Drug Candidate in Selected Asian and South Pacific Countries to Orient Pharma
2. DURECT Corporation Announces Second Quarter 2009 Financial
3. DURECT to Present at the BMO Capital Markets Healthcare Conference
4. DURECT Corporation Invites You to Join Its Second Quarter 2009 Earnings Conference Call
5. DURECT Appoints Dr. Joseph Stauffer as Chief Medical Officer and Executive Vice President, Corporate Strategy
6. DURECT Corporation Invites You to Join its First Quarter 2009 Earnings Conference Call
7. DURECT to Participate in Cowen and Company Healthcare Conference
8. Endo Pharmaceuticals Returns Product Rights to TRANSDUR(TM)-Sufentanil to DURECT
9. DURECT Corporation Invites You to Join Its Fourth Quarter 2008 Earnings Conference Call
10. DURECT Corporation to Participate in Upcoming Healthcare Conferences
11. DURECT Corporation to Participate in Upcoming Healthcare Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2015)... ... August 29, 2015 , ... Dr. Tim Novelli, DC., Founder and President of ... increase acceptance of the chiropractic field in the military. All too often VA hospitals ... Chiropractic was made available to the VA program over a decade ago, the reality ...
(Date:8/29/2015)... ... , ... ProDrop Particles includes over 40 particle backdrops designed for use in ... that users can shrink and stretch in the Final Cut Pro X timeline. Choose ... brightness, scale, speed, range, and flare attributes with intuitive controls found in the top-right ...
(Date:8/29/2015)... ... ... The popular television program VOICES IN AMERICA, hosted by legendary star of the stage ... short segment to the subject of diabetes. Diabetes is a debilitating health condition that ... recent advancements in medical science may prove to be a significant breakthrough that sufferers ...
(Date:8/28/2015)... ... August 28, 2015 , ... Joining a growing number of ... transitioned management companies to partner with Wound Care Advantage (WCA) to utilize the ... , Transitioning wound care management providers can be a complex undertaking. WCA ...
(Date:8/28/2015)... ... August 28, 2015 , ... The Kentucky State Department of Workforce ... the position they are applying for, they are unable to pass the initial drug ... altering drug testing policies in order to be able to hire long-term, skilled talent. ...
Breaking Medicine News(10 mins):Health News:The Patriot Project brings Chiropractic Care to the Armed Forces and their Families - Rapid Release Technology Joins the Effort to Recruit more Doctors to Pledge 2Health News:FCPX Effects Developer, Pixel Film Studios, Releases ProDrop Particles. 2Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 2Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 3Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 4Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 2Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 3Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 4
... Help Plan Members Better Manage Healthcare Needs and Spending , ... Life Insurance Company of America (Guardian), one of the largest ... voluntary benefits for small and mid-sized companies, today introduced enhanced ... their employees will now have access to a broad range ...
... Holdings, Inc. (OTC Bulletin Board: ADLS), a biopharmaceutical ... novel drugs in the therapeutic areas of infection, oncology ... the first quarter ended March 31, 2009. The ... months ended March 31, 2009 was $2.3 million or ...
... ,Eliminates Complications Including Right Heart Failure , ... ... to INTERMACS data recently published in SynCardia’s 2008 Annual ... a bridge-to-transplant rate of 72% at 6 months. This is ...
... Call to Action demonstrates commitment to combating a leading ... and WaterAid America released two new reports today that ... are not responding to clear evidence on child mortality ... Diarrheal disease, a leading killer of children under age ...
... www.hairfairies.com ) opens new salon to help San Diego,s frantic families ... 12 Hair Fairies, the head lice helpers, ( www.hairfairies.com ) ... lice removal salon in San Diego on May 12, 2009. ... a nationwide, full service salon dedicated to removing head lice. ...
... 12 Miami and NY-based Jeffrey Epstein, M.D., FACS, ... has recently established The Foundation for Hair Restoration and ... surgical hair restoration and plastic surgeons. Recognized for ... will help to position The Foundation for Hair Restoration ...
Cached Medicine News:Health News:Guardian Enhances Medical Plans With New Wellness Benefits 2Health News:Guardian Enhances Medical Plans With New Wellness Benefits 3Health News:Guardian Enhances Medical Plans With New Wellness Benefits 4Health News:Advanced Life Sciences Announces First Quarter 2009 Financial Results and Financial Outlook 2Health News:Advanced Life Sciences Announces First Quarter 2009 Financial Results and Financial Outlook 3Health News:Advanced Life Sciences Announces First Quarter 2009 Financial Results and Financial Outlook 4Health News:Advanced Life Sciences Announces First Quarter 2009 Financial Results and Financial Outlook 5Health News:Advanced Life Sciences Announces First Quarter 2009 Financial Results and Financial Outlook 6Health News:Advanced Life Sciences Announces First Quarter 2009 Financial Results and Financial Outlook 7Health News:Advanced Life Sciences Announces First Quarter 2009 Financial Results and Financial Outlook 8Health News:Advanced Life Sciences Announces First Quarter 2009 Financial Results and Financial Outlook 9Health News:INTERMACS: Total Artificial Heart Bridge-to-Transplant Rate 2x Higher ,at 6 Months Than BiVADS and LVADs 2Health News:Two New Reports Highlight Stalled Progress Against Diarrheal Disease: Nearly 1.6 Million Children Die Each Year From These Preventable and Treatable Diseases 2Health News:Two New Reports Highlight Stalled Progress Against Diarrheal Disease: Nearly 1.6 Million Children Die Each Year From These Preventable and Treatable Diseases 3Health News:Two New Reports Highlight Stalled Progress Against Diarrheal Disease: Nearly 1.6 Million Children Die Each Year From These Preventable and Treatable Diseases 4Health News:Lice Removal Salon Offers San Diego an Upscale Solution to an Undesirable Problem 2Health News:Foundation for Hair Restoration Brings Breakthrough Surgical Technology to the U.S. and Announces Nationwide Expansion of Its Network of Top Doctors 2
(Date:8/28/2015)... , Aug. 28, 2015 ... announced the addition of the "Investigation Report ... their offering. Developed by AstraZeneca plc, ... an important drug for the treatment of schizophrenia. ... quetiapine was listed in the Catalogue of Drugs ...
(Date:8/28/2015)... , August 28, 2015 The ... in collaboration with one of the leading academics in the ... (current world record holder in life extension for model animals ... into biology of aging and age-related diseases, primarily, around the ... work has just been published as "Stability analysis of a ...
(Date:8/28/2015)... Denmark and ATLANTA , August ... the US Food and Drug Administration (FDA) cleared the MagVita ... in adult patients who have failed to receive satisfactory improvement ... a non-invasive technique for stimulating neural tissue in the part ... Disorder. The procedure has been proven safe and effective and ...
Breaking Medicine Technology:China Quetiapine Market Investigation Report 2010-2019 2Gero: Physics Meets Biology to Help Defeat Aging 2Gero: Physics Meets Biology to Help Defeat Aging 3Therapy System for Treating Major Depressive Disorder Receives FDA Clearance 2Therapy System for Treating Major Depressive Disorder Receives FDA Clearance 3
... Nashville, Tenn., Oct. 29 Cumberland ... Pty Ltd., an Australian-based specialty pharmaceutical company, today announced ... commercialization of Caldolor® (ibuprofen) Injection in Australia and New ... to treat pain and fever in the hospital setting. ...
... at Thomas Jefferson University in Philadelphia, PA, supported in part ... Journal of Nuclear Medicine reporting preclinical results of a novel ... [1] . "All tumors detected with the new ... on the plasma membrane of the tumor cells." These results ...
Cached Medicine Technology:Cumberland Pharmaceuticals and Phebra Pty Ltd. Sign Exclusive Agreement for Commercialization of Caldolor(R) in Australia and New Zealand 2Cumberland Pharmaceuticals and Phebra Pty Ltd. Sign Exclusive Agreement for Commercialization of Caldolor(R) in Australia and New Zealand 3Cumberland Pharmaceuticals and Phebra Pty Ltd. Sign Exclusive Agreement for Commercialization of Caldolor(R) in Australia and New Zealand 4Cumberland Pharmaceuticals and Phebra Pty Ltd. Sign Exclusive Agreement for Commercialization of Caldolor(R) in Australia and New Zealand 5New Positron Emission Tomography (PET) Biomarker NVB-64 Visualizes Malignant Breast Tumors 2New Positron Emission Tomography (PET) Biomarker NVB-64 Visualizes Malignant Breast Tumors 3
... reagents for the detection of two ... G1691A mutation on the Factor V ... on the Prothrombin gene. Laboratories may ... tests.,, *Analyte Specific Reagents. ...
... the latest and most advanced fecal occult ... line. An immunochemical FOBT (iFOBT) with high ... proven to detect bleeding associated with more ... Because of its superior specificity for lower ...
... When treating a female patient, it's ... of an undetected pregnancy with a ... results at the lowest hCG levels. ... test kit provides semi-quantitative determination of ...
Drugs of Abuse (DoA) Array is used for in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine....
Medicine Products: